AxoGen Inc
AXGN31.980USD
+0.280+0.88%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
1.47BMarket Cap
LossP/E TTM
More Details of AxoGen Inc Company
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
AxoGen Inc Info
Ticker SymbolAXGN
Company nameAxoGen Inc
IPO dateDec 17, 1986
CEODale (Michael Donald)
Number of employees451
Security typeOrdinary Share
Fiscal year-endDec 17
Address13631 Progress Blvd.
CityALACHUA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code32615
Phone13864626817
Websitehttps://www.axogeninc.com/
Ticker SymbolAXGN
IPO dateDec 17, 1986
CEODale (Michael Donald)
Company Executives of AxoGen Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
172.26K
+13.50%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+51.11%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+113.10%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Ms. Kathy Weiler
Ms. Kathy Weiler
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
172.26K
+13.50%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+51.11%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+113.10%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2023
FY2022
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
159.01M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Light Asset Management, LLC
12.59%
BlackRock Institutional Trust Company, N.A.
6.89%
The Vanguard Group, Inc.
5.79%
Morgan Stanley & Co. LLC
4.96%
ArrowMark Colorado Holdings, LLC
4.25%
Other
65.53%
Shareholders
Shareholders
Proportion
First Light Asset Management, LLC
12.59%
BlackRock Institutional Trust Company, N.A.
6.89%
The Vanguard Group, Inc.
5.79%
Morgan Stanley & Co. LLC
4.96%
ArrowMark Colorado Holdings, LLC
4.25%
Other
65.53%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
40.33%
Investment Advisor
29.37%
Hedge Fund
14.38%
Research Firm
6.35%
Individual Investor
5.37%
Family Office
1.76%
Bank and Trust
0.35%
Pension Fund
0.33%
Sovereign Wealth Fund
0.13%
Other
1.63%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
342
42.08M
97.83%
+8.74K
2025Q3
350
42.06M
101.71%
+627.35K
2025Q2
344
41.40M
98.61%
+1.26M
2025Q1
339
40.15M
93.21%
-2.27M
2024Q4
327
37.35M
99.16%
-1.08M
2024Q3
305
37.98M
92.55%
+3.00M
2024Q2
285
37.71M
96.69%
+1.44M
2024Q1
290
36.54M
95.40%
-4.68M
2023Q4
299
34.97M
92.73%
+437.14K
2023Q3
304
34.60M
92.75%
-2.09M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
First Light Asset Management, LLC
4.53M
9.84%
+55.03K
+1.23%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.10M
6.74%
-26.22K
-0.84%
Jun 30, 2025
The Vanguard Group, Inc.
2.72M
5.92%
+191.79K
+7.58%
Jun 30, 2025
Morgan Stanley & Co. LLC
1.93M
4.2%
+348.58K
+21.98%
Jun 30, 2025
ArrowMark Colorado Holdings, LLC
1.63M
3.53%
+34.80K
+2.19%
Jun 30, 2025
Soleus Capital Management, L.P.
1.46M
3.17%
+13.28K
+0.92%
Jun 30, 2025
Wasatch Global Investors Inc
1.43M
3.12%
+659.15K
+85.09%
Jun 30, 2025
Balyasny Asset Management LP
1.93M
4.2%
+1.25M
+183.91%
Jun 30, 2025
Assenagon Asset Management S.A.
1.29M
2.8%
+265.95K
+25.99%
Sep 30, 2025
Armistice Capital LLC
1.11M
2.42%
+573.04K
+106.46%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ROBO Global Healthcare Technology & Innovation ETF
3.51%
State Street SPDR S&P Health Care Equipment ETF
2.3%
iShares Neuroscience and Healthcare ETF
2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
0.97%
Invesco NASDAQ Future Gen 200 ETF
0.74%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
iShares Micro-Cap ETF
0.19%
Fidelity Enhanced Small Cap ETF
0.18%
Principal U.S. Small-Cap ETF
0.15%
Franklin US Small Cap Multifactor Index ETF
0.14%
View more
ROBO Global Healthcare Technology & Innovation ETF
Proportion3.51%
State Street SPDR S&P Health Care Equipment ETF
Proportion2.3%
iShares Neuroscience and Healthcare ETF
Proportion2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion0.97%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.74%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.21%
iShares Micro-Cap ETF
Proportion0.19%
Fidelity Enhanced Small Cap ETF
Proportion0.18%
Principal U.S. Small-Cap ETF
Proportion0.15%
Franklin US Small Cap Multifactor Index ETF
Proportion0.14%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of AxoGen Inc?
The top five shareholders of AxoGen Inc are:
First Light Asset Management, LLC holds 4.53M shares, accounting for 9.84% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.10M shares, accounting for 6.74% of the total shares.
The Vanguard Group, Inc. holds 2.72M shares, accounting for 5.92% of the total shares.
Morgan Stanley & Co. LLC holds 1.93M shares, accounting for 4.20% of the total shares.
ArrowMark Colorado Holdings, LLC holds 1.63M shares, accounting for 3.53% of the total shares.
First Light Asset Management, LLC holds 4.53M shares, accounting for 9.84% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.10M shares, accounting for 6.74% of the total shares.
The Vanguard Group, Inc. holds 2.72M shares, accounting for 5.92% of the total shares.
Morgan Stanley & Co. LLC holds 1.93M shares, accounting for 4.20% of the total shares.
ArrowMark Colorado Holdings, LLC holds 1.63M shares, accounting for 3.53% of the total shares.
What are the top three shareholder types of AxoGen Inc?
The top three shareholder types of AxoGen Inc are:
First Light Asset Management, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
First Light Asset Management, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
How many institutions hold shares of AxoGen Inc (AXGN)?
As of 2025Q4, 342 institutions hold shares of AxoGen Inc, with a combined market value of approximately 42.08M, accounting for 97.83% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -3.88%.
What is the biggest source of revenue for AxoGen Inc?
In FY2023, the -- business generated the highest revenue for AxoGen Inc, amounting to -- and accounting for --% of total revenue.
